Madrigal pharmaceuticals, inc. (MDGL)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
License and milestone revenue

-

-

-

-

-

-

-

-

6,731

4,572

125,701

Cost sharing reimbursements, net

-

-

-

-

-

-

-

-

-

9,253

18,544

Total collaboration revenues

-

-

-

-

-

-

-

-

6,731

13,825

144,245

Grant revenue

-

-

-

-

-

-

-

147

853

978

-

Total revenues

-

-

-

-

-

-

-

147

7,584

14,803

144,245

Operating expenses:
Research and development

72,324

25,389

24,390

15,933

2,427

68,205

71,860

49,412

41,464

40,252

51,054

General and administrative

22,648

15,293

7,672

9,290

805

15,746

15,699

11,676

11,552

11,449

12,651

Restructuring

-

-

-

-

-

-

-

-

-

-

1,236

Total operating expenses

94,972

40,682

32,062

25,223

3,232

83,951

87,559

61,088

53,016

51,701

64,941

Loss from operations

-94,972

-40,682

-32,062

-25,223

-3,232

-83,951

-87,559

-60,941

-45,432

-36,898

79,304

Interest income (expense), net

-

-

-

-

-

-2,210

-2,633

-1,849

-1,948

-569

-216

Interest expense

-

-

-

1,213

3,611

-

-

-

-

-

-

Interest income

11,024

7,671

558

48

-

-

-

-

-

-

-

Other income

-

200

350

-

-

-

-

-

-

-

-

Net loss

-83,900

-32,811

-31,154

-26,388

-6,844

-86,161

-90,192

-62,790

-47,380

-37,467

79,088

Net loss per common share:
Basic and diluted net loss per common share (in dollars per share)

-5.45

-2.22

-2.54

-5.07

-40.03

-0.87

-1.27

-1.06

-1.00

-0.93

-

Basic and diluted weighted average number of common shares outstanding

15,394

14,796

12,244

5,204

171

98,489

70,976

59,411

47,197

40,365

-

Basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

2.33

Diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

2.32

Basic weighted average number of common shares outstanding (in shares)

-

-

-

-

-

-

-

-

-

-

33,887

Diluted weighted average number of common shares outstanding (in shares)

-

-

-

-

-

-

-

-

-

-

34,118